Finland – Pharmaceutical products – Onasemnogeeniabeparvoveekki-infuusionesteen (Zolgensma® 2x10exp13 vektorigenomia/ml
HUS-Yhtymä awarded €8.0M to Novartis Finland Oy for Healthcare & Medical in January 2025 — one of 1,479 awards this buyer has made, above its typical award size.
Buying agency
HUS-YhtymäWinning supplier
Novartis Finland OyContract description
Finland – Pharmaceutical products – Onasemnogeeniabeparvoveekki-infuusionesteen (Zolgensma® 2x10exp13 vektorigenomia/ml infuusioneste, liuos) hankinta
Related awards · HUS-Yhtymä
1,479 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-500745-2024Renalis Oü€40.0M21 Aug 2024 Healthcare
- ocds-ted-206235-2024Gasum Oy€35.0M08 Apr 2024 Energy
- ocds-ted-432352-2026DHL Supply Chain (Finland) Oy€25.4M25 Jun 2026 Professional Services
Other wins · Novartis Finland Oy
5 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-239917-2025HUS-Yhtymä€4.5M14 Apr 2025 Healthcare
- ocds-ted-62268-2026HUS-Yhtymä€2.0M28 Jan 2026 Healthcare
- ocds-ted-763637-2025-2HUS-YhtymäNot disclosed18 Nov 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for HUS-Yhtymä and Novartis Finland Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back